| Submission to first decision
(The average time from manuscript submission to desk rejection, direct rejection/acceptance or assignment to the first editor) Note: For manuscripts that fully comply with the journal template. However, this timeframe does not apply to manuscripts with formatting or guideline deficiencies. If a manuscript is returned to the authors for corrections, the administrative review process will restart from the re-submission date. |
3 weeks |
|---|---|
| Submission to decision after review (For papers that are sent to review, the average time from submission to receipt of first editor decision) | 6 weeks |
| Submission to final decision (The average time from manuscript submission to the final editorial decision) | 16 weeks |
| Submission to publication (The average time from acceptance to publication. Manuscript published in early view are also included in this calculation) | 24 weeks |
ACTA Pharmaceutica Sciencia
2005 , Vol 47 , Num 3
FORMULATION AND EVALUATION OF CONTROLLED RELEASE DILTIAZEM PELLETS USING EUDRAGIT NE40
Department of Pharmacy, Islamia University, Bahawalpur-Pakistan
Viewed :
20065
-
Downloaded :
6018
A release controlling film coat around diltiazem pellets was developed with Eudrgit NE40 and the effects of percent drug layering, pH and stirring speed of dissolution media on drug release were also evaluated. Diltiazem HCL aqueous solutions were applied onto inert pellets to produce drug pellets, which were subsequently coated with aqueous polymer dispersion using bottom spray Fluidized-bed coater. Coated pellets were cured at 37°C for 24 h. The release profile of coated pellets was found to be inversely proportional to the thickness of the polymer coat and desirable controlled release characteristics could be achieved by manipulating the coating levels. The percent drug layering onto inert pellets had no effect on the release rate of coated pellets. Moreover, diltiazem HCL release was fairly independent of pH and stirring speed.
Keywords :
CONTROLLED RELEASE PELLETS, COATING, EUDRAGIT, DILTIAZEM, FLUIDIZED-BED
